TARGETED DELIVERY OF CYTOTOXIC DRUGS A) TO ACTIVATED LYMPHOCYTES IN PATIENTS WITH TRANSPLANTED ORGANS, B) AS RADIOSENSITIZERS TO CANCER CELLS IN PATIENTS UNDERGOING RADIATION THERAPY, AND C) IN VITAMIN-BINDING PROTEINS AS DRUG CARRIERS IN THE DIAGNOSIS AND TREATMENT OF CANCER - Patent 1305051

(19)

(11)

EP 1 305 051 A2

(12)

(88)	Date of publication A3:
	08.08.2002

(43)	Date of publication:
	02.05.2003 Bulletin 2003/18

(21)	Application number: 01950547.8

(22)	Date of filing: 28.06.2001

(51)	International Patent Classification (IPC)⁷: A61K 51/00, A61K 38/00, A61K 38/16, C07K 17/00, C08H 1/00

(86)	International application number:
	PCT/US0120/444

(87)	International publication number:
	WO 0200/0170 (03.01.2002 Gazette 2002/01)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

28.06.2000 US 214427 P
28.06.2000 US 214388 P
28.06.2000 US 214389 P

(71)	Applicant: Faulk, Ward Page
	Indianapolis, IN 46240 (US)

(72)	Inventor:
	Faulk, Ward Page Indianapolis, IN 46240 (US)

(74)	Representative: Eyles, Christopher Thomas
	W.P. THOMPSON & CO.Celcon House289-293 High Holborn London WC1V 7HU London WC1V 7HU (GB)

(54)	TARGETED DELIVERY OF CYTOTOXIC DRUGS A) TO ACTIVATED LYMPHOCYTES IN PATIENTS WITH TRANSPLANTED ORGANS, B) AS RADIOSENSITIZERS TO CANCER CELLS IN PATIENTS UNDERGOING RADIATION THERAPY, AND C) IN VITAMIN-BINDING PROTEINS AS DRUG CARRIERS IN THE DIAGNOSIS AND TREATMENT OF CANCER